Incruse® Ellipta® (umeclidinium bromide inhaler 62.5/25mcg per inhalation) is a Prescription Medicine. Incruse Ellipta is used for long-term regular treatment to relieve symptoms in adult patients with Chronic Obstructive Pulmonary Disease (COPD). Incruse Ellipta is a fully funded medicine. Use strictly as directed. Do not take Incruse Ellipta to treat asthma or to relieve acute symptoms. Always carry your reliever inhaler. This medicine has risks and benefits. Tell your doctor: If you are taking other medicines or herbal remedies, you have heart disease or high blood pressure, asthma, an enlarged prostate, difficulty passing urine, bladder problems or narrow-angle glaucoma. Side effects: Sore throat with or without a runny nose, cough, painful and frequent urination, infection of the upper airways, pain of the sinuses, faster heart bear, feeling of pressure or pain in the cheeks and forehead. If symptoms continue or you have side effects, see your doctor, pharmacist or health care professional. For more information, see Incruse Ellipta Consumer Medicine Information at www.medsafe.govt.nz. Normal doctor’s office visit fees apply. Ask your doctor if Incruse Ellipta is right for you.